Skip to main content
. 2019 Dec 18;12(1):4. doi: 10.3390/cancers12010004

Figure 5.

Figure 5

Overview of a mitochondria-targeted drug-free approach. In this approach, the monomer is designed with the ability to either polymerize, self-assemble, or aggregate inside the cancer mitochondria taking advantage of cancer mitochondria characteristics such as higher negative membrane potential, higher basicity inside the matrix or overproduction of ROS. The resulting supramolecular system leads to mitochondria damage, causing cell death.